Header Logo

Connection

Chad Hamilton to Middle Aged

Back to Details
This is a "connection" page, showing publications Chad Hamilton has written about Middle Aged.
Chad Hamilton
Connection Strength
0.882
Middle Aged
  1. Clinicopathologic characteristics associated with long-term survival in advanced epithelial ovarian cancer: an NRG Oncology/Gynecologic Oncology Group ancillary data study. Gynecol Oncol. 2018 02; 148(2):275-280.
    View in: PubMed
    Score: 0.067
  2. Survival advantage of marriage in uterine cancer patients contrasts poor outcome for widows: a Surveillance, Epidemiology and End Results study. Gynecol Oncol. 2015 Feb; 136(2):328-35.
    View in: PubMed
    Score: 0.055
  3. Growing teratoma syndrome: Brief communication and algorithm for management. Aust N Z J Obstet Gynaecol. 2013 Jun; 53(3):318-21.
    View in: PubMed
    Score: 0.049
  4. The impact of disease distribution on survival in patients with stage III epithelial ovarian cancer cytoreduced to microscopic residual: a Gynecologic Oncology Group study. Gynecol Oncol. 2011 Sep; 122(3):521-6.
    View in: PubMed
    Score: 0.043
  5. Gemcitabine-associated large vessel vasculitis presenting as fever of unknown origin. J Clin Rheumatol. 2010 Jun; 16(4):181-2.
    View in: PubMed
    Score: 0.040
  6. Clinical aspects of uterine papillary serous carcinoma. Curr Opin Obstet Gynecol. 2008 Feb; 20(1):26-33.
    View in: PubMed
    Score: 0.034
  7. Acute postoperative thrombotic thrombocytopenic purpura following hysterectomy and lymphadenectomy for endometrial cancer. Gynecol Oncol. 2007 Aug; 106(2):423-6.
    View in: PubMed
    Score: 0.032
  8. The effect of adjuvant chemotherapy versus whole abdominopelvic radiation on the survival of patients with advanced stage uterine papillary serous carcinoma. Gynecol Oncol. 2006 Nov; 103(2):679-83.
    View in: PubMed
    Score: 0.031
  9. Impact of adjuvant therapy on survival of patients with early-stage uterine papillary serous carcinoma. Int J Radiat Oncol Biol Phys. 2005 Nov 01; 63(3):839-44.
    View in: PubMed
    Score: 0.029
  10. Factors Associated With Survival Disparities Between Non-Hispanic Black and White Patients With Uterine Cancer. JAMA Netw Open. 2023 04 03; 6(4):e238437.
    View in: PubMed
    Score: 0.024
  11. Conditional estimates for uterine serous cancer: Tools for survivorship counseling and planning. Gynecol Oncol. 2022 07; 166(1):90-99.
    View in: PubMed
    Score: 0.023
  12. Is imaging at intermediate doses necessary during dobutamine stress magnetic resonance imaging? J Cardiovasc Magn Reson. 2001; 3(4):297-302.
    View in: PubMed
    Score: 0.021
  13. Racial disparities in uterine and ovarian carcinosarcoma: A population-based analysis of treatment and survival. Gynecol Oncol. 2020 04; 157(1):67-77.
    View in: PubMed
    Score: 0.020
  14. Impact of adjuvant treatment and prognostic factors in stage I uterine leiomyosarcoma patients treated in Commission on Cancer?-accredited facilities. Gynecol Oncol. 2020 04; 157(1):121-130.
    View in: PubMed
    Score: 0.020
  15. Jupiter microtubule-associated homolog 1 (JPT1): A predictive and pharmacodynamic biomarker of metformin response in endometrial cancers. Cancer Med. 2020 02; 9(3):1092-1103.
    View in: PubMed
    Score: 0.019
  16. Prospective follow-up of quality of life for participants undergoing risk-reducing salpingo-oophorectomy or ovarian cancer screening in GOG-0199: An NRG Oncology/GOG study. Gynecol Oncol. 2020 01; 156(1):131-139.
    View in: PubMed
    Score: 0.019
  17. Final analysis of a phase I/IIa trial of the folate-binding protein-derived E39 peptide vaccine to prevent recurrence in ovarian and endometrial cancer patients. Cancer Med. 2019 08; 8(10):4678-4687.
    View in: PubMed
    Score: 0.019
  18. Biomarker panel for early detection of endometrial cancer in the Prostate, Lung, Colorectal, and Ovarian cancer screening trial. Am J Obstet Gynecol. 2019 11; 221(5):472.e1-472.e10.
    View in: PubMed
    Score: 0.019
  19. Nomogram for Predicting Individual Survival After Recurrence of Advanced-Stage, High-Grade Ovarian Carcinoma. Obstet Gynecol. 2019 02; 133(2):245-254.
    View in: PubMed
    Score: 0.018
  20. Racial disparities in molecular subtypes of endometrial cancer. Gynecol Oncol. 2018 04; 149(1):106-116.
    View in: PubMed
    Score: 0.017
  21. Correlation between Surgeon's assessment and radiographic evaluation of residual disease in women with advanced stage ovarian cancer reported to have undergone optimal surgical cytoreduction: An NRG Oncology/Gynecologic Oncology Group study. Gynecol Oncol. 2018 06; 149(3):525-530.
    View in: PubMed
    Score: 0.017
  22. Relative Effects of Age, Race, and Stage on Mortality in Gestational Choriocarcinoma. Int J Gynecol Cancer. 2018 02; 28(2):338-345.
    View in: PubMed
    Score: 0.017
  23. Predictive modeling for determination of microscopic residual disease at primary cytoreduction: An NRG Oncology/Gynecologic Oncology Group 182 Study. Gynecol Oncol. 2018 01; 148(1):49-55.
    View in: PubMed
    Score: 0.017
  24. Surgical outcomes among elderly women with endometrial cancer treated by laparoscopic hysterectomy: a NRG/Gynecologic Oncology Group study. Am J Obstet Gynecol. 2018 01; 218(1):109.e1-109.e11.
    View in: PubMed
    Score: 0.017
  25. Impact of age at diagnosis on racial disparities in endometrial cancer patients. Gynecol Oncol. 2018 04; 149(1):12-21.
    View in: PubMed
    Score: 0.017
  26. Interim analysis of a phase I/IIa trial assessing E39+GM-CSF, a folate binding protein vaccine, to prevent recurrence in ovarian and endometrial cancer patients. Oncotarget. 2017 Feb 28; 8(9):15912-15923.
    View in: PubMed
    Score: 0.016
  27. Factors associated with deciding between risk-reducing salpingo-oophorectomy and ovarian cancer screening among high-risk women enrolled in GOG-0199: An NRG Oncology/Gynecologic Oncology Group study. Gynecol Oncol. 2017 04; 145(1):122-129.
    View in: PubMed
    Score: 0.016
  28. Progesterone potentiates the growth inhibitory effects of calcitriol in endometrial cancer via suppression of CYP24A1. Oncotarget. 2016 Nov 22; 7(47):77576-77590.
    View in: PubMed
    Score: 0.016
  29. What is the role of retroperitoneal exploration in optimally debulked stage IIIC epithelial ovarian cancer? An NRG Oncology/Gynecologic Oncology Group ancillary data study. Cancer. 2017 May 15; 123(6):985-993.
    View in: PubMed
    Score: 0.016
  30. Impact of histology and surgical approach on survival among women with early-stage, high-grade uterine cancer: An NRG Oncology/Gynecologic Oncology Group ancillary analysis. Gynecol Oncol. 2016 Dec; 143(3):460-465.
    View in: PubMed
    Score: 0.016
  31. Femoral artery occlusion following pelvic cancer surgery. Gynecol Oncol. 1996 Oct; 63(1):151-3.
    View in: PubMed
    Score: 0.016
  32. Nestin: A biomarker of aggressive uterine cancers. Gynecol Oncol. 2016 Mar; 140(3):503-11.
    View in: PubMed
    Score: 0.015
  33. Does aggressive surgery improve outcomes? Interaction between preoperative disease burden and complex surgery in patients with advanced-stage ovarian cancer: an analysis of GOG 182. J Clin Oncol. 2015 Mar 10; 33(8):937-43.
    View in: PubMed
    Score: 0.014
  34. Pathologic findings at risk-reducing salpingo-oophorectomy: primary results from Gynecologic Oncology Group Trial GOG-0199. J Clin Oncol. 2014 Oct 10; 32(29):3275-83.
    View in: PubMed
    Score: 0.013
  35. A clinicopathologic study of vaginal intraepithelial neoplasia. Obstet Gynecol. 2013 Dec; 122(6):1223-30.
    View in: PubMed
    Score: 0.013
  36. Upper abdominal procedures in advanced stage ovarian or primary peritoneal carcinoma patients with minimal or no gross residual disease: an analysis of Gynecologic Oncology Group (GOG) 182. Gynecol Oncol. 2013 Sep; 130(3):487-92.
    View in: PubMed
    Score: 0.012
  37. Should stage IIIC ovarian cancer be further stratified by intraperitoneal vs. retroperitoneal only disease?: a Gynecologic Oncology Group study. Gynecol Oncol. 2012 Jan; 124(1):53-8.
    View in: PubMed
    Score: 0.011
  38. Racial disparities in recurrence among patients with early-stage endometrial cancer: is recurrence increased in black patients who receive estrogen replacement therapy? Cancer. 2008 Sep 15; 113(6):1431-7.
    View in: PubMed
    Score: 0.009
  39. A novel technique for the enrichment of primary ovarian cancer cells. Am J Obstet Gynecol. 2007 Nov; 197(5):507.e1-5.
    View in: PubMed
    Score: 0.008
  40. Outcomes of women with metachronous breast and ovarian carcinomas. Gynecol Oncol. 2006 Oct; 103(1):190-4.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.